Max D. Driscoll
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- Biochemical and Molecular Research 3
- DNA Repair Mechanisms 2
- DNA and Nucleic Acid Chemistry 2
- Cancer therapeutics and mechanisms 2
-
- Tuberculosis Research and Epidemiology 5
- Co-authors
- Kirsty J. McLean (5 shared papers)Andrew W. Munro (5 shared papers)Sam Hay (6 shared papers)Adrian J. Dunford (1 shared paper)Rajasekhar Neeli (1 shared paper)Colin Levy (2 shared papers)David Leys (2 shared papers)Stephen E. J. Rigby (2 shared papers)
- Journals
- FEBS Journal (1 paper)ACS Catalysis (1 paper)Journal of Biological Chemistry (1 paper)Archives of Biochemistry and Biophysics (1 paper)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Max D. Driscoll
13 papers receiving 353 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 138
- Infectious Diseases 102
- Molecular Biology 198
- Molecular Medicine 11
- Organic Chemistry 62
Countries citing papers authored by Max D. Driscoll
This map shows the geographic impact of Max D. Driscoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max D. Driscoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max D. Driscoll more than expected).
Fields of papers citing papers by Max D. Driscoll
This network shows the impact of papers produced by Max D. Driscoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max D. Driscoll. The network helps show where Max D. Driscoll may publish in the future.
Co-authors
The 25 scholars most cited alongside Max D. Driscoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 92 | |
| 2 | 2007 | 65 | |
| 3 | 2017 | 56 | |
| 4 | 2010 | 28 | |
| 5 | 2010 | 24 | |
| 6 | 2014 | 21 | |
| 7 | 2016 | 20 | |
| 8 | 2014 | 17 | |
| 9 | 2014 | 12 | |
| 10 | 2016 | 8 | |
| 11 | 2016 | 7 | |
| 12 | 2002 | 5 | |
| 13 | 2007 | 3 |
About Max D. Driscoll
Max D. Driscoll is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Materials Chemistry and Physical and Theoretical Chemistry, having authored 13 papers that have together received 358 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Biochemical and Molecular Research (3 papers), DNA Repair Mechanisms (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Cancer therapeutics and mechanisms (2 papers), Luminescence and Fluorescent Materials (2 papers) and Supramolecular Chemistry and Complexes (1 paper). The work is most often cited by research in Pharmacology (138 citations), Infectious Diseases (102 citations), Molecular Biology (198 citations), Molecular Medicine (11 citations) and Organic Chemistry (62 citations). Max D. Driscoll has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Kirsty J. McLean, Andrew W. Munro, Sam Hay, Adrian J. Dunford, Rajasekhar Neeli, Colin Levy, David Leys, Stephen E. J. Rigby, Irina A. Pikuleva and Natalia Mast. Their work appears in journals such as FEBS Journal, ACS Catalysis, Journal of Biological Chemistry, Archives of Biochemistry and Biophysics and Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.